|
1
|
Soares ER, Lima WG, Machado RP, et al:
Cardiac and renal effects induced by different exercise workloads
in renovascular hypertensive rats. Braz J Med Biol Res. 44:573–582.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lecellier CH, Dunoyer P, Arar K, et al: A
cellular microRNA mediates antiviral defense in human cells.
Science. 308:557–560. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Berezikov E, Guryev V, van de Belt J, et
al: Phylogenetic shadowing and computational identification of
human microRNA genes. Cell. 120:21–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jost D, Nowojewski A and Levine E: Small
RNA biology is systems biology. BMB Rep. 44:11–21. 2011. View Article : Google Scholar
|
|
5
|
Lukiw WJ: Micro-RNA speciation in fetal,
adult and Alzheimer’s disease hippocampus. Neuroreport. 18:297–300.
2007.PubMed/NCBI
|
|
6
|
van Rooij E, Sutherland LB, Liu N, et al:
A signature pattern of stress-responsive microRNAs that can evoke
cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA.
103:18255–18260. 2006.PubMed/NCBI
|
|
7
|
Yang B, Lin H, Xiao J, et al: The
muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic
potential by targeting GJA1 and KCNJ2. Nat Med. 13:486–491. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carè A, Catalucci D, Felicetti F, et al:
MicroRNA-133 controls cardiac hypertrophy. Nat Med. 13:613–618.
2007.
|
|
9
|
van Rooij E, Sutherland LB, Thatcher JE,
et al: Dysregulation of microRNAs after myocardial infarction
reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci
USA. 105:13027–13032. 2008.PubMed/NCBI
|
|
10
|
Sayed D, Hong C, Chen IY, Lypowy J and
Abdellatif M: MicroRNAs play an essential role in the development
of cardiac hypertrophy. Circ Res. 100:416–424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Elia L, Contu R, Quintavalle M, et al:
Reciprocal regulation of microRNA-1 and insulin-like growth
factor-1 signal transduction cascade in cardiac and skeletal muscle
in physiological and pathological conditions. Circulation.
120:2377–2385. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Horie T, Ono K, Nishi H, et al:
MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15
and is involved in metabolic control in cardiac myocytes. Biochem
Biophys Res Commun. 389:315–320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thum T, Gross C, Fiedler J, et al:
MicroRNA-21 contributes to myocardial disease by stimulating MAP
kinase signalling in fibroblasts. Nature. 456:980–984. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin Z, Murtaza I, Wang K, Jiao J, Gao J
and Li PF: miR-23a functions downstream of NFATc3 to regulate
cardiac hypertrophy. Proc Natl Acad Sci USA. 106:12103–12108. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wiesel P, Mazzolai L, Nussberger J and
Pedrazzini T: Two-kidney, one clip and one-kidney, one clip
hypertension in mice. Hypertension. 29:1025–1030. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matsumoto-Ida M, Takimoto Y, Aoyama T,
Akao M, Takeda T and Kita T: Activation of TGF-beta1-TAK1-p38 MAPK
pathway in spared cardiomyocytes is involved in left ventricular
remodeling after myocardial infarction in rats. Am J Physiol Heart
Circ Physiol. 290:H709–H715. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mascareno E, Galatioto J, Rozenberg I, et
al: Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling
via transcriptional modulation of diverse hypertrophic and fibrotic
responses and angiotensin II-transforming growth factor β (TGF-β1)
signaling axis. J Biol Chem. 287:13084–13093. 2012.PubMed/NCBI
|
|
18
|
Liao W, Yu C, Wen J, et al: Adiponectin
induces interleukin-6 production and activates STAT3 in adult mouse
cardiac fibroblasts. Biol Cell. 101:263–272. 2009. View Article : Google Scholar : PubMed/NCBI
|
